Richard Kovacs to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Richard Kovacs has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.217
-
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. J Am Med Dir Assoc. 2020 Jul; 21(7):909-914.e2.
Score: 0.181
-
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. JAMA Cardiol. 2017 04 01; 2(4):370-380.
Score: 0.036